FICHE-YOUNG: FIrst-line treatment CHoicE in hormone receptor positive (HR+)/HER2- negative metastatic breast cancer patients (MBC) ≤45 years old. A large observational multicenter cohort survival analysis

Authors :: Gaëtane Simon
E. Jacquet
C. Cailliot
F. Divanon
Laurence Vanlemmens
Marc Debled
M. Breton
A. Gonçalves
Paul-Henri Cottu
Suzette Delaloge
C. Laurent
Thomas Bachelot
Thierry Petit
M. Leheurteur
M-A Mouret-Reynier
Bruno Coudert
Audrey Lardy-Cleaud
Emmanuel Chamorey
Barbara Pistilli
L. Campion
Source :: Annals of Oncology. 28:v92-v93
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
medicine.medical_specialty
business.industry
HER2 negative
Hematology
medicine.disease
Metastatic breast cancer
First line treatment
Hormone receptor
Internal medicine
Cohort
medicine
Observational study
business
Survival analysis

Full Text Access

Tools